Evidence map›Paper›PMID 40242607›Full record

ArticleInternational journal of nanomedicine2025

Green Synthesis and Characterization of Silver Nanoparticles Using

Cumali Keskin, Seyhan Aslan, Mehmet Fırat Baran, Ayşe Baran, Aziz Eftekhari, Mehmet Tevfik Adıcan, Elham Ahmadian, Sevki Arslan, Ali Jimale Mohamed

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Green-synthesizedRSC advances · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Advancing glioblastoma therapy with surface-modified nanoparticles.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cumali KeskinDepartment of Medical Services and Techniques, Vocational School of Health Services, Mardin Artuklu University, Mardin, Turkiye.
Seyhan AslanDepartment of Biology, Graduate Education Institute, Mardin Artuklu University, Mardin, 47200, Turkiye.
Mehmet Fırat BaranDepartment of Food Technology, Vocational School of Technical Sciences, Batman University, Batman, Turkiye.
Ayşe BaranDepartment of Plant and Animal Production, Medicinal and Aromatic Plants Program, Kiziltepe Vocational School, Marin Artuklu University, Mardin, Turkiye.
Aziz EftekhariDepartment of Biochemistry, Faculty of Science, Ege University, Izmir, Turkiye.
Mehmet Tevfik AdıcanDepartment of Electricity and Energy, Vocational School, Mardin Artuklu University, Mardin, Turkiye.
Elham AhmadianKidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sevki ArslanDepartment of Biology, Faculty of Science, Pamukkale University, Denizli, Turkiye.
Ali Jimale MohamedDepartment of Pharmacology, Faculty of Medicine, Somali National University, Mogadishu, 801, Somalia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: The synthesized biogenic silver nanoparticles (AO-AgNPs) were characterized using different techniques. The antimicrobial activity of AgNPs against common bacterial pathogenic strains was determined by the minimum inhibitory concentration (MIC) method. The presence of phytochemicals was determined by LSMS/MS. The MTT assay was used to investigate AO-AgNPs' cytotoxic activity in malignant (LnCap, Caco2, MDA-MB2, A549) and healthy (HEK-293) cell lines. Results: LC-MS/MS analysis detected the presence of rich phytochemicals that may be responsible for reduction reactions. Biogenic AO-AgNPs exhibited effective inhibition of the growth of pathogenic microorganisms at low concentrations. The most effective antimicrobial activity was measured as 0.5 µg/mL MIC against Conclusion: The obtained results showed that AO could be an important source for the synthesis of AgNPs. Especially their ability to inhibit the growth of antibiotic-resistant pathogenic bacteria at low concentrations compared to common antibiotics indicates that AO-AgNPs can be used as biomedical agents in various areas. Moreover, their suppressive effect on cancerous cell lines showed that they have the potential to be used as an anticancer agent, but due to their proliferative effect on healthy cell lines, care should be taken in determining the appropriate dose.

Indexed as

Anti-Infective AgentsMetal NanoparticlesPlant ExtractsSilverAnti-Bacterial AgentsAntineoplastic AgentsCandida albicansCell Line, TumorCell SurvivalEscherichia coliGreen Chemistry TechnologyHEK293 CellsHumansMicrobial Sensitivity TestsPlant LeavesStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsAntineoplastic AgentsPlant ExtractsSilverAg NPsAnchusa officinalisantimicrobial activitybiochemical compositioncytotoxic activitygreen synthesis

Identifiers

PMID40242607
PMCPMC12002332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.